Judith L. Thijs

Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis

Judith L. Thijs, Ian Strickland, Carla A.F.M. Bruijnzeel-Koomen et al. · Journal of Allergy and Clinical Immunology · 2017 · 161 citations · Full text

Medicine, Dermatology, Immunology +16

Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry

Lieneke F.M. Ariëns, Jorien van der Schaft, Daphne S. Bakker et al. · Allergy · 2019 · 149 citations · Full text

Life Sciences, Dermatology, Pharmacotherapy +15

Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers

Daphne S. Bakker, Stefan Nierkens, Edward F. Knol et al. · Journal of Allergy and Clinical Immunology · 2020 · 124 citations · Full text

Medicine, Dermatology, Immunology +16

Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry

Lieneke F.M. Ariëns, Jorien van der Schaft, Lotte S. Spekhorst et al. · Journal of the American Academy of Dermatology · 2020 · 91 citations · Full text

Life Sciences, Dermatology, Immunology +12

Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis

Daphne S. Bakker, Marlot van der Wal, Lukas E. M. Heeb et al. · Journal of Investigative Dermatology · 2021 · 81 citations · Full text

Life Sciences, Dermatology, Immunology +17